Floatz logo

Therapeutic Asset Ratings

5,108 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
T-Cell Acute Lymphoblastic Leukemia
University of WashingtonP3BB (66)
Astx727
Chronic Myelomonocytic Leukemia
Taiho Oncology, Inc.P3BB (66)
Astx727
Myelodysplastic Syndrome
Taiho Oncology, Inc.P3BB (66)
Asundexian
Ischemic Stroke
BayerP3BB (66)
Ateganosine
Non-Small Cell Lung Carcinoma
Maia BiotechnologyP3BB (66)
Atezolizumab
Castration-Resistant Prostate Carcinoma
Cancer Research UKP3BB (66)
Axicabtagene Ciloleucel
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Zhujiang HospitalP3BB (66)
Axicabtagene Ciloleucel
Non-Hodgkin Lymphoma
Lyell Immunopharma, Inc.P3BB (66)
az-3102
Niemann-Pick Disease Type C
Azafaros B.V.P3BB (66)
Azacitidine
Chronic Myelomonocytic Leukemia
The University of Hong KongP3BB (66)
azd5305
Metastatic Prostate Carcinoma
AstraZenecaP3BB (66)
AZD9291
Non-Small Cell Lung Carcinoma
AstraZenecaP3BB (66)
BAY 59-7939
Atrial Fibrillation
BayerP3BB (66)
Befotertinib
Non-Small Cell Lung Carcinoma
Hebei Medical University Fourth HospitalP3BB (66)
Bendamustine
Diffuse Large B-Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P3BB (66)
Bendamustine
Lymphoplasmacytic Lymphoma
City of Hope Medical CenterP3BB (66)
Benzamide, N-[(3R)-3-(2-chloro-5-fluorophenyl)-6-(5-cyano[1,2,4]triazolo[1,5-a]pyridin-6-yl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-3-fluoro-5-(trifluoromethyl)-
Her2-Receptor Negative Breast Cancer
Relay Therapeutics, Inc.P3BB (66)
Benzeneethanamine, N-ethyl-?-methyl-4-(trifluoromethyl)-, hydrochloride, (±)-
Infantile Spasms
Children's Hospital of Orange CountyP3BB (66)
Bezuclastinib
Gastrointestinal Stromal Tumor
Cogent Biosciences, Inc.P3BB (66)
Binimetinib
Colon Carcinoma
AIO-Studien-gGmbHP3BB (66)
BLEOMYCIN
Ovarian Sex Cord-Stromal Tumor
Beihua KongP3BB (66)
Blinatumomab
Acute Lymphoblastic Leukemia
M.D. Anderson Cancer CenterP3BB (66)
Blinatumomab
Down Syndrome
National Cancer Institute (NCI)P3BB (66)
Bl-M14D1
Small Cell Lung Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3BB (66)
Brentuximab Vedotin
Hodgkin'S Lymphoma, Mixed Cellularity
National Cancer Institute (NCI)P3BB (66)
Showing 976 to 1000 of 5,108 assets
PreviousPage 40 of 205Next